Compass Pathways… a psychedelic monopoly
COMPASS patent… compared to proprietary insulin formulations and asthma inhalers created to increase corporate profits… will share similar issues to “big pharma, big tech, big ag [agriculture], and other monopoly-heavy industries.” COMPASS’s attempt to dismiss the dispute against their patent… “Although Patent Owner does not address the substance of Petitioner’s challenge, after considering the arguments…
Recent Comments